Cargando…

Serum Immunoglobulin G Levels to Porphyromonas gingivalis Peptidylarginine Deiminase Affect Clinical Response to Biological Disease-Modifying Antirheumatic Drug in Rheumatoid Arthritis

OBJECTIVES: To determine whether serum immunity to Porphyromonas gingivalis peptidylarginine deiminase (PPAD) affects the clinical response to biological disease-modifying antirheumatic drug (bDMARD) in patients with rheumatoid arthritis (RA). METHODS: In a retrospective study, rheumatologic and per...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kobayashi, Tetsuo, Ito, Satoshi, Kobayashi, Daisuke, Shimada, Atsushi, Narita, Ichiei, Murasawa, Akira, Nakazono, Kiyoshi, Yoshie, Hiromasa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4844134/ https://www.ncbi.nlm.nih.gov/pubmed/27111223 http://dx.doi.org/10.1371/journal.pone.0154182

Ejemplares similares

Porphyromonas gingivalis exacerbates ulcerative colitis via Porphyromonas gingivalis peptidylarginine deiminase
por: Zhao, Xida, et al.
Publicado: (2021)

Crystal structure of Porphyromonas gingivalis peptidylarginine deiminase: implications for autoimmunity in rheumatoid arthritis
por: Montgomery, Anna B, et al.
Publicado: (2016)

The peptidylarginine deiminase gene is a conserved feature of Porphyromonas gingivalis
por: Gabarrini, Giorgio, et al.
Publicado: (2015)

Generation and characterisation of Porphyromonas gingivalis mutant lacking peptidylarginine deiminase activity
por: Muñoz-Atienza, Estefanía, et al.
Publicado: (2017)

Interleukin‐6 receptor inhibitor tocilizumab ameliorates periodontal inflammation in patients with rheumatoid arthritis and periodontitis as well as tumor necrosis factor inhibitors
por: Kobayashi, Tetsuo, et al.
Publicado: (2015)

There's no place like OM: Vesicular sorting and secretion of the peptidylarginine deiminase of Porphyromonas gingivalis
por: Gabarrini, Giorgio, et al.
Publicado: (2018)

The Efficacy of Biological Disease-modifying Antirheumatic Drugs on Sarcopenia in Patients with Rheumatoid Arthritis
por: Hasegawa, Eriko, et al.
Publicado: (2023)

Role of Porphyromonas gingivalis’s peptidylarginine deiminase in multispecies biofilm formation and bacterial adherence to host cells
por: Aliko, Ardita, et al.
Publicado: (2017)

An Analysis of the Neuropathic Pain Components in Rheumatoid Arthritis Patients
por: Ito, Satoshi, et al.
Publicado: (2017)

Heightened immune response to autocitrullinated Porphyromonas gingivalis peptidylarginine deiminase: a potential mechanism for breaching immunologic tolerance in rheumatoid arthritis
por: Quirke, Anne-Marie, et al.
Publicado: (2014)

Porphyromonas gingivalis Peptidylarginine Deiminase, a Key Contributor in the Pathogenesis of Experimental Periodontal Disease and Experimental Arthritis
por: Gully, Neville, et al.
Publicado: (2014)

Structure and mechanism of a bacterial host-protein citrullinating virulence factor, Porphyromonas gingivalis peptidylarginine deiminase
por: Goulas, Theodoros, et al.
Publicado: (2015)

An Analysis of the Biological Disease-modifying Antirheumatic Drug-free Condition of Adalimumab-treated Rheumatoid Arthritis Patients
por: Ito, Satoshi, et al.
Publicado: (2018)

Porphyromonas gingivalis Facilitates the Development and Progression of Destructive Arthritis through Its Unique Bacterial Peptidylarginine Deiminase (PAD)
por: Maresz, Katarzyna J., et al.
Publicado: (2013)

Dropping anchor: attachment of peptidylarginine deiminase via A-LPS to secreted outer membrane vesicles of Porphyromonas gingivalis
por: Gabarrini, Giorgio, et al.
Publicado: (2018)

Impact of Porphyromonas gingivalis Peptidylarginine Deiminase on Bacterial Biofilm Formation, Epithelial Cell Invasion, and Epithelial Cell Transcriptional Landscape
por: Aliko, Ardita, et al.
Publicado: (2018)

Peptidylarginine Deiminase of Porphyromonas gingivalis Modulates the Interactions between Candida albicans Biofilm and Human Plasminogen and High-Molecular-Mass Kininogen
por: Karkowska-Kuleta, Justyna, et al.
Publicado: (2020)

Analysis of the peptidylarginine deiminase V gene in rheumatoid arthritis
por: Caponi, L, et al.
Publicado: (2003)

Anti-peptidylarginine deiminase-4 antibodies at mucosal sites can activate peptidylarginine deiminase-4 enzyme activity in rheumatoid arthritis
por: Demoruelle, M. Kristen, et al.
Publicado: (2021)

Circulating levels of carbamylated protein and neutrophil extracellular traps are associated with periodontitis severity in patients with rheumatoid arthritis: A pilot case-control study
por: Kaneko, Chihiro, et al.
Publicado: (2018)

Features of the citrullinating peptidylarginine deiminase enzymes
por: Vossenaar, ER, et al.
Publicado: (2004)

Peptidylarginine deiminase isoforms expressed in the synovial membrane of rheumatoid arthritis patients
por: Chapuy-Regaud, S, et al.
Publicado: (2003)

Tocilizumab treatment safety in rheumatoid arthritis in a patient with multiple sclerosis: a case report
por: Sato, Hiroe, et al.
Publicado: (2014)

Functional haplotypes in citrullinating enzyme peptidylarginine deiminase 4 are associated with rheumatoid arthritis
por: Yamamoto, K, et al.
Publicado: (2003)

Bacterial and human peptidylarginine deiminases: targets for inhibiting the autoimmune response in rheumatoid arthritis?
por: Mangat, Pamela, et al.
Publicado: (2010)

Smoking is not linked to the development of anti-peptidylarginine deiminase 4 autoantibodies in rheumatoid arthritis
por: Cappelli, Laura C., et al.
Publicado: (2018)

Autoantibodies to Peptidylarginine Deiminase 2 Are Associated With Less Severe Disease in Rheumatoid Arthritis
por: Darrah, Erika, et al.
Publicado: (2018)

Peptidylarginine Deiminase 2 Gene Polymorphisms in Subjects with Periodontitis Predispose to Rheumatoid Arthritis
por: Massarenti, Laura, et al.
Publicado: (2022)

Putative Roles for Peptidylarginine Deiminases in COVID-19
por: Arisan, Elif Damla, et al.
Publicado: (2020)

In vivo expression of peptidylarginine deiminase in Drosophila melanogaster
por: Mahneva, Olena, et al.
Publicado: (2020)

Deimination and Peptidylarginine Deiminases in Skin Physiology and Diseases
por: Méchin, Marie-Claire, et al.
Publicado: (2020)

Effectiveness and Safety of Golimumab for Patients ≥75 Years Old with Rheumatoid Arthritis
por: Kurosawa, Yoichi, et al.
Publicado: (2022)

Association between serum IgG antibody titers against Porphyromonas gingivalis and liver enzyme levels: A cross-sectional study in Sado Island
por: Takamisawa, Kei, et al.
Publicado: (2020)

Increased citrullination and expression of peptidylarginine deiminases independently of P. gingivalis and A. actinomycetemcomitans in gingival tissue of patients with periodontitis
por: Engström, Marianne, et al.
Publicado: (2018)

Expression of Peptidylarginine Deiminase Type 4 in Ovarian Tumors
por: Wang, Lin, et al.
Publicado: (2010)

Role of peptidylarginine deiminase type 4 in gastric cancer
por: Xin, Jiang, et al.
Publicado: (2016)

Implications of Porphyromonas gingivalis peptidyl arginine deiminase and gingipain R in human health and diseases
por: Chow, Yoke Chan, et al.
Publicado: (2022)

Effects of tofacitinib on the clinical features of periodontitis in patients with rheumatoid arthritis: two case reports
por: Kobayashi, Tetsuo, et al.
Publicado: (2019)

Peptidylarginine Deiminases as Drug Targets in Neonatal Hypoxic–Ischemic Encephalopathy
por: Lange, Sigrun
Publicado: (2016)

Peptidylarginine deiminase 4 promotes age-related organ fibrosis
por: Martinod, Kimberly, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_h77jg082ianht21tve626us4j7